Advanced search
Publication Cover
mAbs Volume 1, 2009 - Issue 2
Submit an article Journal homepage
3,279
Views
78
CrossRef citations to date
0
Altmetric
Perspective

mAbs

A business perspective

Pablo A. Scolnik The Scolnik Group Biotechnology Consultants, LLCCorrespondence[email protected]
Pages 179-184 | Received 08 Oct 2008, Accepted 21 Dec 2008, Published online: 01 Mar 2009

Citations (78)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Jayant Arora, John M Hickey, Ranajoy Majumdar, Reza Esfandiary, Steven M Bishop, Hardeep S Samra, C Russell Middaugh, David D Weis & David B Volkin. (2015) Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody. mAbs 7:3, pages 525-539.
Read now
Renaud Respaud, Denis Marchand, Christelle Parent, Thibaut Pelat, Philippe Thullier, Jean-François Tournamille, Marie-Claude Viaud-Massuard, Patrice Diot, Mustapha Si-Tahar, Laurent Vecellio & Nathalie Heuzé-Vourc’h. (2014) Effect of formulation on the stability and aerosol performance of a nebulized antibody. mAbs 6:5, pages 1347-1355.
Read now
Yuniel Fernández-Marrero & Alejandro López-Requena. (2011) Lonely killers. mAbs 3:6, pages 528-534.
Read now
Hossein Samadi & David Sultzer. (2011) Solanezumab for Alzheimer's disease. Expert Opinion on Biological Therapy 11:6, pages 787-798.
Read now
Marcus Duvall, Norma Bradley & Ryan N. Fiorini. (2011) A novel platform to produce human monoclonal antibodies. mAbs 3:2, pages 203-208.
Read now
Geoffrey A Kerchner & Adam L Boxer. (2010) Bapineuzumab. Expert Opinion on Biological Therapy 10:7, pages 1121-1130.
Read now
Laura A. Sullivan & Rolf A. Brekken. (2010) The VEGF family in cancer and antibody-based strategies for their inhibition. mAbs 2:2, pages 165-175.
Read now

Articles from other publishers (71)

Carolina Duarte, Chiaki Yamada, Bidii Ngala, Christopher Garcia, Juliet Akkaoui, Maxim Birsa, Anny Ho, Amilia Nusbaum, Hawra AlQallaf, Vanchit John & Alexandru Movila. (2023) Effects of IL‐34 and anti‐IL‐34 neutralizing mAb on alveolar bone loss in a ligature‐induced model of periodontitis. Molecular Oral Microbiology.
Crossref
Caitlin V. Wood, Vladimir I. Razinkov, Wei Qi, Christopher J. Roberts, Jan Vermant & Eric M. Furst. (2023) Antibodies Adsorbed to the Air–Water Interface Form Soft Glasses. Langmuir 39:22, pages 7775-7782.
Crossref
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski & Ursula Wiedermann. (2022) Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14:22, pages 5678.
Crossref
Joshua Tobias, Mirjana Drinić, Sandra Högler, Katharina Ambroz, Karin Baier, Petra Kodajova, Erwin Tomasich, Anna S. Berghoff, Anna Schmid, Erika Garner-Spitzer, Lukas Kenner, Michael Kundi, Christoph C. Zielinski & Ursula Wiedermann. (2022) Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model. Translational Oncology 19, pages 101378.
Crossref
Fabien Thoreau & Vijay Chudasama. (2022) Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry. RSC Chemical Biology 3:2, pages 140-169.
Crossref
J. Tobias, E. Garner-Spitzer, M. Drinić & U. Wiedermann. (2022) Vaccination against Her-2/neu, with focus on peptide-based vaccines. ESMO Open 7:1, pages 100361.
Crossref
J. Tobias, P. Steinberger, M. Drinić & U. Wiedermann. (2021) Emerging targets for anticancer vaccination: PD-1. ESMO Open 6:5, pages 100278.
Crossref
Ludger Johannes. (2021) The Cellular and Chemical Biology of Endocytic Trafficking and Intracellular Delivery—The GL–Lect Hypothesis. Molecules 26:11, pages 3299.
Crossref
Caitlin V. Wood, Vladimir I. Razinkov, Wei Qi, Eric M. Furst & Christopher J. Roberts. (2021) A Rapid, Small-Volume Approach to Evaluate Protein Aggregation at Air-Water Interfaces. Journal of Pharmaceutical Sciences 110:3, pages 1083-1092.
Crossref
K.B. Megha & P.V. Mohanan. (2021) Role of immunoglobulin and antibodies in disease management. International Journal of Biological Macromolecules 169, pages 28-38.
Crossref
Hannah R Reese, Xingqing Xiao, Calvin C Shanahan, Wenning Chu, George A Van Den Driessche, Denis Fourches, Ruben G Carbonell, Carol K Hall & Stefano Menegatti. (2020) Novel peptide ligands for antibody purification provide superior clearance of host cell protein impurities. Journal of Chromatography A 1625, pages 461237.
Crossref
Joshua Tobias, Claire Battin, Annika De Sousa Linhares, Michael Lebens, Karin Baier, Katharina Ambroz, Mirjana Drinić, Sandra Högler, Aleksandra Inic-Kanada, Erika Garner-Spitzer, Matthias Preusser, Lukas Kenner, Michael Kundi, Christoph C. Zielinski, Peter Steinberger & Ursula Wiedermann. (2020) A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors. Frontiers in Immunology 11.
Crossref
Caitlin V. Wood, Sean McEvoy, Vladimir I. Razinkov, Wei Qi, Eric M. Furst & Christopher J. Roberts. (2020) Kinetics and Competing Mechanisms of Antibody Aggregation via Bulk- and Surface-Mediated Pathways. Journal of Pharmaceutical Sciences 109:4, pages 1449-1459.
Crossref
Mark Pagkaliwangan, Jonathan Hummel, Xhorxhi Gjoka, Marc Bisschops & Mark Schofield. (2018) Optimized Continuous Multicolumn Chromatography Enables Increased Productivities and Cost Savings by Employing More Columns. Biotechnology Journal 14:2, pages 1800179.
Crossref
Jonathan Hummel, Mark Pagkaliwangan, Xhorxhi Gjoka, Terence Davidovits, Rick Stock, Thomas Ransohoff, Rene Gantier & Mark Schofield. (2018) Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales. Biotechnology Journal 14:2, pages 1700665.
Crossref
Andy C. Tran, Mi-Young KimRajko Reljic. (2019) Emerging Themes for the Role of Antibodies in Tuberculosis. Immune Network 19:4.
Crossref
Mahlet A. Woldeyes, Wei Qi, Vladimir I. Razinkov, Eric M. Furst & Christopher J. Roberts. (2019) How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?. Journal of Pharmaceutical Sciences 108:1, pages 142-154.
Crossref
Déborah Caucheteur, Gautier Robin, Vincent Parez & Pierre Martineau. 2018. Antibody Engineering. Antibody Engineering 93 108 .
Déborah Caucheteur, Gautier Robin, Vincent Parez & Pierre Martineau. 2018. Phage Display. Phage Display 239 253 .
António L. Grilo, Marília Mateus, Maria R. Aires-Barros & Ana M. Azevedo. (2017) Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non-Protein-A Chromatographic Platform Based on Process Economics. Biotechnology Journal 12:12, pages 1700260.
Crossref
John Steven, Mischa R. Müller, Miguel F. Carvalho, Obinna C. Ubah, Marina Kovaleva, Gerard Donohoe, Thomas Baddeley, Dawn Cornock, Kenneth Saunders, Andrew J. Porter & Caroline Jane Barelle. (2017) In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development. Frontiers in Immunology 8.
Crossref
A. Makkouk, V. Sundaram, C. Chester, S. Chang, A.D. Colevas, J.B. Sunwoo, H. Maecker, M. Desai & H.E. Kohrt. (2017) Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy. Annals of Oncology 28:2, pages 415-420.
Crossref
Alexandru Movila, Takenobu Ishii, Abdullah Albassam, Wichaya Wisitrasameewong, Mohammed Howait, Tsuguno Yamaguchi, Montserrat Ruiz‐Torruella, Laila Bahammam, Kazuaki Nishimura, Thomas Van Dyke & Toshihisa Kawai. (2016) Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions. Journal of Bone and Mineral Research 31:9, pages 1688-1700.
Crossref
Jennifer L. Purdie, Ronald L. Kowle, Amie L. Langland, Chetan N. Patel, Anli Ouyang & Donald J. Olson. (2016) Cell culture media impact on drug product solution stability. Biotechnology Progress 32:4, pages 998-1008.
Crossref
Robert P. Sundel. 2016. Pediatric Allergy: Principles and Practice. Pediatric Allergy: Principles and Practice 112 123.e1 .
Jennifer C. Rea, Benny S. Freistadt, Daniel McDonald, Dell Farnan & Yajun Jennifer Wang. (2015) Capillary ion-exchange chromatography with nanogram sensitivity for the analysis of monoclonal antibodies. Journal of Chromatography A 1424, pages 77-85.
Crossref
Szabolcs Fekete, Alain Beck, Jean-Luc Veuthey & Davy Guillarme. (2015) Ion-exchange chromatography for the characterization of biopharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 113, pages 43-55.
Crossref
Matthew C. Cook, Sherif J. Kaldas, Gauri Muradia, Michael Rosu-Myles & Jeremy P. Kunkel. (2015) Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody. Journal of Chromatography B 997, pages 162-178.
Crossref
Richard Alldread & Jonathan Robinson. (2015) Biopharmaceutical factory of the future. Pharmaceutical Bioprocessing 3:4, pages 293-304.
Crossref
Nathan D. Gundacker & John W. Baddley. (2015) Fungal Infections in the Era of Biologic Therapies. Current Clinical Microbiology Reports 2:2, pages 76-83.
Crossref
Reena Verma, Ramakrishnan Ravichandran, Naatamai S. Jayaprakash, Ashok Kumar, Mookambeswaran A. Vijayalakshmi & Krishnan Venkataraman. (2015) Adjuvant poly( N -isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis . Biotechnology Journal 10:5, pages 772-782.
Crossref
Hossein Salimi-Moosavi, Aaron Winters, Christina Abbott, Jennifer Patel, Todd Hager, Vimal Patel, Judy Shih, Yao Zhuang & Mark Ma. (2015) A multifactorial screening strategy to identify anti-idiotypic reagents for bioanalytical support of antibody therapeutics. Analytical Biochemistry 470, pages 52-60.
Crossref
Varsha Joshi, Tarun Shivach, Nitin Yadav & Anurag S. Rathore. (2014) Circular Dichroism Spectroscopy as a Tool for Monitoring Aggregation in Monoclonal Antibody Therapeutics. Analytical Chemistry 86:23, pages 11606-11613.
Crossref
Richard M. Alldread, John R. Birch, Hilary K. Metcalfe, Suzanne Farid, Andrew J. Racher, Robert J. Young & Mohsan Khan. 2014. Industrial Scale Suspension Culture of Living Cells. Industrial Scale Suspension Culture of Living Cells 410 462 .
Frank R. Brennan, Annick Cauvin, Jay Tibbitts & Alison Wolfreys. (2014) Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases. Drug Development Research, pages n/a-n/a.
Crossref
Sarmistha Ray-Saha, Thomas Huber & Thomas P. Sakmar. (2014) Antibody Epitopes on G Protein-Coupled Receptors Mapped with Genetically Encoded Photoactivatable Cross-Linkers. Biochemistry 53:8, pages 1302-1310.
Crossref
Yao‐Ming Huang, Rashmi Kshirsagar, Barbara Woppmann & Thomas Ryll. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins 67 96 .
Franziska Roth-Walter, Angelika B. Riemer, Erika Jensen-Jarolim & Hannes Stockinger. 2014. Comparative Medicine. Comparative Medicine 219 266 .
Nico Lingg, Eddy Tan, Beate Hintersteiner, Muriel Bardor & Alois Jungbauer. (2013) Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range. Journal of Chromatography A 1319, pages 65-71.
Crossref
Heather H. Shih, Paula Miller & Douglas C. Harnish. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 28 .
Szabolcs Fekete, Michael W. Dong, Taylor Zhang & Davy Guillarme. (2013) High resolution reversed phase analysis of recombinant monoclonal antibodies by ultra-high pressure liquid chromatography column coupling. Journal of Pharmaceutical and Biomedical Analysis 83, pages 273-278.
Crossref
Prachi Bhoskar, Brett Belongia, Robert Smith, Seongkyu Yoon, Tyler Carter & Jin Xu. (2013) Free light chain content in culture media reflects recombinant monoclonal antibody productivity and quality. Biotechnology Progress 29:5, pages 1131-1139.
Crossref
Brian D. Wright & Suzanne E. Lapi. (2013) Designing the Magic Bullet? The Advancement of Immuno-PET into Clinical Use. Journal of Nuclear Medicine 54:8, pages 1171-1174.
Crossref
Lisa M. Jones, Hao Zhang, Weidong Cui, Sandeep Kumar, Justin B. Sperry, James A. Carroll & Michael L. Gross. (2013) Complementary MS Methods Assist Conformational Characterization of Antibodies with Altered S–S Bonding Networks. Journal of the American Society for Mass Spectrometry 24:6, pages 835-845.
Crossref
Waliza AnsarShyamasree Ghosh. (2013) Monoclonal Antibodies: A Tool in Clinical Research. Indian Journal of Clinical Medicine 4, pages IJCM.S11968.
Crossref
Szabolcs Fekete, Anne-Laure Gassner, Serge Rudaz, Julie Schappler & Davy Guillarme. (2013) Analytical strategies for the characterization of therapeutic monoclonal antibodies. TrAC Trends in Analytical Chemistry 42, pages 74-83.
Crossref
Søren Buus, Johan Rockberg, Björn Forsström, Peter Nilsson, Mathias Uhlen & Claus Schafer-Nielsen. (2012) High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh-density Peptide Microarrays. Molecular & Cellular Proteomics 11:12, pages 1790-1800.
Crossref
Nico Lingg, Peiqing Zhang, Zhiwei Song & Muriel Bardor. (2012) The sweet tooth of biopharmaceuticals: Importance of recombinant protein glycosylation analysis. Biotechnology Journal 7:12, pages 1462-1472.
Crossref
Szabolcs Fekete, Serge Rudaz, Jean-Luc Veuthey & Davy Guillarme. (2012) Impact of mobile phase temperature on recovery and stability of monoclonal antibodies using recent reversed-phase stationary phases. Journal of Separation Science 35:22, pages 3113-3123.
Crossref
Felicity NE Gavins. (2012) New technologies: only a snapshot, but look how far we have come!. Current Opinion in Pharmacology 12:5, pages 567-568.
Crossref
Annika Järviluoma, Tomas Strandin, Sebastian Lülf, Jérôme Bouchet, Anna R. Mäkelä, Matthias Geyer, Serge Benichou & Kalle Saksela. (2012) High-Affinity Target Binding Engineered via Fusion of a Single-Domain Antibody Fragment with a Ligand-Tailored SH3 Domain. PLoS ONE 7:7, pages e40331.
Crossref
Eva L. Decker & Ralf Reski. (2011) Glycoprotein production in moss bioreactors. Plant Cell Reports 31:3, pages 453-460.
Crossref
William J. Galush, Lan N. Le & Jamie M.R. Moore. (2012) Viscosity Behavior of High-Concentration Protein Mixtures. Journal of Pharmaceutical Sciences 101:3, pages 1012-1020.
Crossref
Arkadiusz Pierzchalski, Monika Hebeisen, Anja Mittag, Jozsef Bocsi, Marco Di Berardino & Attila Tarnok. (2012) Label-free hybridoma cell culture quality control by a chip-based impedance flow cytometer. Lab on a Chip 12:21, pages 4533.
Crossref
Jennifer C. Rea, G. Tony Moreno, Lisa Vampola, Yun Lou, Bjorn van Haan, Guillaume Tremintin, Laura Simmons, Adrian Nava, Yajun Jennifer Wang & Dell Farnan. (2012) Capillary size exclusion chromatography with picogram sensitivity for analysis of monoclonal antibodies purified from harvested cell culture fluid. Journal of Chromatography A 1219, pages 140-146.
Crossref
Deron R. Herr. 2012. International Review of Cell and Molecular Biology Volume 297. International Review of Cell and Molecular Biology Volume 297 45 81 .
William Renwick. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF 225 247 .
Gautier Robin & Pierre Martineau. 2012. Antibody Engineering. Antibody Engineering 109 122 .
Sal Bottiglieri, Benyam Muluneh, Stephanie Sutphin, Lew Iacovelli & Val Adams. (2010) Blood pressure control in patients receiving bevacizumab in an outpatient cancer center. Journal of Oncology Pharmacy Practice 17:4, pages 333-338.
Crossref
U. Iyer & V.J. Kadambi. (2011) Antibody drug conjugates — Trojan horses in the war on cancer. Journal of Pharmacological and Toxicological Methods 64:3, pages 207-212.
Crossref
David Gurwitz. (2011) Biomarkers: improving the cost-effectiveness of biological drugs for autoimmune disorders. Drug Development Research 72:7, pages 549-552.
Crossref
Agnès Maillet, Laurent Guilleminault, Etienne Lemarié, Stéphanie Lerondel, Nicolas Azzopardi, Jérôme Montharu, Nicolas Congy-Jolivet, Pascale Reverdiau, Brigitte Legrain, Christelle Parent, Dominique-Henri Douvin, José Hureaux, Yves Courty, Michèle De Monte, Patrice Diot, Gilles Paintaud, Alain Le Pape, Hervé Watier & Nathalie Heuzé-Vourc’h. (2011) The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors. Pharmaceutical Research 28:9, pages 2147-2156.
Crossref
Manuel Arruebo, Nuria Vilaboa, Berta Sáez-Gutierrez, Julio Lambea, Alejandro Tres, Mónica Valladares & África González-Fernández. (2011) Assessment of the Evolution of Cancer Treatment Therapies. Cancers 3:3, pages 3279-3330.
Crossref
María Vázquez-Rey & Dietmar A. Lang. (2011) Aggregates in monoclonal antibody manufacturing processes. Biotechnology and Bioengineering 108:7, pages 1494-1508.
Crossref
Imke A.J. Dreesen & Martin Fussenegger. (2011) Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells. Biotechnology and Bioengineering 108:4, pages 853-866.
Crossref
Agustin Lage & Tania Crombet. (2011) Control of Advanced Cancer: The Road to Chronicity. International Journal of Environmental Research and Public Health 8:3, pages 683-697.
Crossref
Thorsten Klamp, Jens Schumacher, Georg Huber, Christoph Kühne, Ulrich Meissner, Abderraouf Selmi, Thomas Hiller, Sebastian Kreiter, Jürgen Markl, Özlem Türeci & Ugur Sahin. (2011) Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases. Cancer Research 71:2, pages 516-527.
Crossref
Steven Simoens, Thomas De Rijdt & Paul Declerck. (2010) Monoclonal antibodies: indications, budget impact and use. Journal of Pharmaceutical Health Services Research 1:3, pages 123-130.
Crossref
Andrew C. Chan & Paul J. Carter. (2010) Therapeutic antibodies for autoimmunity and inflammation. Nature Reviews Immunology 10:5, pages 301-316.
Crossref
Olivier Cochet & Michel Chartrain. (2009) Du milligramme à la tonne d’anticorps monoclonaux. médecine/sciences 25:12, pages 1078-1084.
Crossref
Michaela Gebauer & Arne Skerra. (2009) Engineered protein scaffolds as next-generation antibody therapeutics. Current Opinion in Chemical Biology 13:3, pages 245-255.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.